Skip to content

The effect of transcranial direct current stimulation on the quality of postoperative recovery in patients undergoing laparoscopic gastric volume reduction surgery: A randomized, double-blind, controlled trial

The effect of transcranial direct current stimulation on the quality of postoperative recovery in patients undergoing laparoscopic gastric volume reduction surgery: A randomized, double-blind, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119352
Enrollment
Unknown
Registered
2026-02-26
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative recovery quality, nausea and vomiting, and pain

Interventions

Experimental group:Before anesthesia induction, after the patient regained consciousness after the surgery and was extubated, on the first day after the operation, using the transcranial direct curren
Control group:Place the electrodes of the instrument on the corresponding area, but give a false stimulus

Sponsors

Xuzhou Medical University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18 - 65 years old; 2. BMI >= 30 [(kg)/m^2]; 3. ASA classification is II - III grade; 4. Patients scheduled to undergo laparoscopic gastric volume reduction surgery; 5. Able to understand the research process and the use of various assessment scales, and able to communicate effectively with the researchers.

Exclusion criteria

Exclusion criteria: 1. Refuse to sign the trial consent form; 2. Those with implanted electrophysiological devices in the body; 3. Those with local skin damage or infections; 4. Those with communication disorders or who cannot cooperate with the researchers, such as language comprehension disorders, mental illnesses, etc.; 5. Those who have been taking hormones, antiemetic or analgesic drugs for a long time. 6. Patients with gastroesophageal reflux; 7. Have a history of neurological or mental diseases in the past.

Design outcomes

Primary

MeasureTime frame
The postoperative recovery quality score (QoR-40) on the first day after surgery;

Secondary

MeasureTime frame
Postoperative recovery quality scores (QoR-40) on the 2nd, 3rd and 7th days after surgery;Gastrointestinal dysfunction scores (I-FEED) on the 1st, 2nd, 3rd and 7th days after surgery;The Pittsburgh Sleep Quality Index scores (PSQI) on the 1st, 2nd, 3rd and 7th days after the surgery;The anxiety and depression scores (HADS) on the 1st, 2nd, 3rd and 7th days after the surgery;Postoperative pain scores in the recovery room, 6 hours, 12 hours, 24 hours, 48 hours, 72 hours, and 7 days after surgery;Postoperative nausea and vomiting scores at the recovery room, 6 hours, 12 hours, 24 hours, 48 hours, 72 hours, and 7 days after surgery;The consumption of rescue drugs (for pain relief and antiemesis) within 48 hours after the operation;The time when the patient was extubated;Patient self-reported first exhaust time after surgery;First underground activity time;The date of the patient's discharge;

Countries

China

Contacts

Public ContactCao Junli

Xuzhou Medical University Affiliated Hospital

caojl0310@aliyun.com+86 151 6216 0809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026